Tengion (TNGN) Stock Price, News & Analysis

Company Overview

Tengion, Inc. was a biotechnology company focused on regenerative medicine and the development of personalized, implantable organs and tissues. Its approach used a patient’s own cells to create replacement or augmentative biological products intended to restore organ function and reduce the risks associated with donor organs and synthetic implants.

The company’s leading programs included the Neo-Kidney Augment, an investigational product designed to support kidney function in patients with chronic kidney disease, and earlier programs involving engineered bladder and urinary conduit tissues. Tengion developed these products for potential use in urology and other areas where tissue regeneration could address unmet medical needs.

Tengion was based in the United States and operated as a clinical-stage biotechnology company. The company experienced financial difficulties and ultimately ceased active operations, so it is not generally regarded as an operating developer of regenerative-medicine products today. Information about its current leadership, commercial activities and geographic operations is limited.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 10,000 shs
• Average Volume: 6,051 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:TNGN
• CIK: 1296391
• Web: www.tengion.com
• Phone: (336) 722-5855
• Fax: N/A
• Employees: 25
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A